bioRxiv (Cold Spring Harbor Laboratory),
Journal Year:
2024,
Volume and Issue:
unknown
Published: Sept. 6, 2024
Abstract
The
cGAS/STING-mediated
type
I
interferon
response
can
augment
antitumor
activity,
while
the
regulatory
factors
within
this
innate
immune
remain
elusive.
Herein
we
found
that
RNA
m
6
A
methyltransferase
METTL3
was
upregulated
in
lung
carcinoma
tissues.
Elevated
level
correlated
with
diminished
CD8
+
T
cell
infiltration
and
cancer
progression
patients.
deficiency
exacerbated
nuclear
DNA
leakage
into
cytoplasm,
activating
cGAS
pathway
thereby
enhancing
anti-tumor
immunity.
Mechanistically,
reduced
homologous
recombination
repair
efficacy
via
downregulation
of
MSH5,
a
mutS
family
protein
involved
mismatch
repair,
leading
to
increased
cytosolic
levels.
methylation
A2521
MSH5
stabilized
its
mRNA
binding
IGF2BP2.
On
other
hand,
A1545
at
CDS
decreased
stability
regulates
expression.
Functionally,
knockdown
sensitized
cells
PARP
inhibitors.
In
vivo
clinical
data
confirmed
positive
roles
inhibition-activated
cGAS/STING
axis
tumor
growth
adenocarcinoma
progression.
Collectively,
inhibition
activates
immunity
induction
expression,
which
turn
regulate
inhibitor
carcinoma.
Molecular Cancer,
Journal Year:
2025,
Volume and Issue:
24(1)
Published: Jan. 15, 2025
Biometallic
ions
play
a
crucial
role
in
regulating
the
immune
system.
In
recent
years,
cancer
immunotherapy
has
become
breakthrough
treatment,
achieving
good
efficacy
wide
range
of
cancers
with
its
specificity
and
durability
advantages.
However,
existing
therapies
still
face
challenges,
such
as
tolerance
escape.
(e.g.
zinc,
copper,
magnesium,
manganese,
etc.)
can
assist
enhancing
through
activation
cells,
enhancement
tumor
antigen
presentation,
improvement
microenvironment.
addition,
biometallic
derivatives
directly
inhibit
cell
progression
offer
possibility
effectively
overcoming
limitations
current
by
promoting
responses
reducing
immunosuppressive
signals.
This
review
explores
potential
application
prospects
immunotherapy,
providing
new
ideas
for
future
clinical
metal
part
helping
to
guide
development
more
effective
safe
therapeutic
regimens.
ACS Nano,
Journal Year:
2025,
Volume and Issue:
unknown
Published: Feb. 11, 2025
As
natural
agonists
of
the
stimulator
interferon
genes
(STING),
cyclic
dinucleotides
(CDNs)
have
been
identified
as
promising
immunotherapies
that
trigger
a
potent
immune
response
against
tumors.
However,
low
stability,
rapid
clearance,
inadequate
cellular
uptake,
and
inefficient
cytosol
localization
heavily
hinder
therapeutic
efficacy
hydrophilic
negatively
charged
2′,
3′-cyclic-GMP-AMP
(cGAMP).
How
to
efficiently
deliver
cGAMP
into
endoplasmic
reticulum
(ER)
activate
STING
for
priming
remains
challenging.
Here,
we
report
pH-responsive
guanidinium-rich
nanoagonist
(nPGSA)
delivery
cGAMP.
Compared
with
free
cGAMP,
nPGSA
achieves
up
37.4-fold
enhancement
internalization.
The
pH-sensitive
guanidinium-functional
design
facilitates
quick
release
endosome
escape,
thus
enabling
precise
ER
targeting
33.9-fold
amplification
sensibilization.
Furthermore,
through
modulation
tumor-associated
macrophage
(TAM)
polarization,
elicits
antigen-specific
sustained
tumor
regression
in
melanoma-
neuroblastoma-bearing
mice.
Our
study
provides
strategy
it
offers
insights
function
modulating
microenvironment
cancer
immunotherapy.
Advanced Science,
Journal Year:
2024,
Volume and Issue:
11(38)
Published: Aug. 9, 2024
The
highly
immunosuppressive
tumor
microenvironment
(TME)
restricts
the
efficient
activation
of
immune
responses.
To
restore
surveillance
system
for
robust
activation,
vast
efforts
are
devoted
to
normalizing
TME.
Here,
a
manganese-doped
layered
double
hydroxide
(Mn-LDH)
is
developed
potent
anti-tumor
immunity
by
reversing
Mn-LDH
synthesized
via
one-step
hydrothermal
method.
In
addition
inherent
proton
neutralization
capacity
LDH,
introduction
manganese
oxide
endows
LDH
with
an
additional
ability
produce
oxygen.
effectively
releases
Mn
Advanced Science,
Journal Year:
2025,
Volume and Issue:
unknown
Published: Feb. 14, 2025
Abstract
Chemo‐immunotherapy,
combining
systemic
chemotherapeutic
drugs
and
immune
checkpoint
blockers,
is
a
promising
paradigm
in
cancer
treatment.
However,
challenges
such
as
limited
induction
of
responses
toxicity
have
hindered
its
clinical
applications.
Here,
zeolite
imidazolate
framework‐8
(ZIF‐8)
that
encapsulates
mitoxantrone
(MIT),
an
cell
death
(ICD)‐inducing
agent
(MIT@ZIF‐8),
synthesized
using
one‐pot
aqueous‐phase
process.
ZIF‐8
serves
dual‐functional
nanomaterial
for
chemo‐immunotherapy:
carrier
to
enhance
tumor
uptake
MIT
improved
chemotherapy
efficacy,
pyroptosis
inducer
amplify
MIT‐induced
ICD
augmented
anti‐tumor
responses.
As
result,
vivo
administration
MIT@ZIF‐8
markedly
inhibits
growth
both
immunologically
“hot”
colon
“cold”
prostate
cancer.
Moreover,
treatment
increases
the
abundance
cytotoxic
CD8
+
T
cells
reduces
amount
immunosuppressive
regulatory
tumors,
thereby
enhancing
immunity
sensitizing
anti‐CTLA‐4
immunotherapy.
In
summary,
offers
highly
translational
approach
chemo‐immunotherapy.
Advanced Functional Materials,
Journal Year:
2025,
Volume and Issue:
unknown
Published: March 16, 2025
Abstract
The
cyclic
guanosine
monophosphate‐adenosine
monophosphate
synthase
(cGAS)‐stimulator
of
interferon
genes
(STING)
signaling
pathway
is
an
important
innate
immune
that
has
shown
remarkable
potential
in
cancer
immunotherapy.
However,
the
clinical
therapeutic
efficacy
limited
due
to
insufficient
penetration
STING
agonists
into
tumors.
In
this
study,
a
special
piezo‐STING
agonist
(ZnS‐Cur@CM,
Z/C@M)
composed
zinc
sulfide
nanosheets,
curcumin,
and
tumor
cell
membranes
based
on
principle
piezocatalytic
for
water
splitting
generate
gas
designed,
which
effectively
reduces
intratumoral
delivery
resistance,
markedly
enhancing
depth
drug
Under
ultrasound,
Z/C@M
rapidly
decomposes
interstitial
fluid
produce
hydrogen,
leading
decreased
pressure
increased
accumulation
within
tumor.
Additionally,
reactive
oxygen
species
generated
by
piezocatalysis
damage
mitochondria
cells,
resulting
release
mitochondrial
DNA
activation
cGAS‐STING
pathway.
Moreover,
released
Zn
2+
acidic
microenvironment
further
enhances
signal
transduction.
reduce
through
improve
tumors,
also
activates
treatment.
This
study
provides
novel
perspective
ACS Omega,
Journal Year:
2025,
Volume and Issue:
unknown
Published: March 17, 2025
Immunotherapy
is
a
critical
modality
in
cancer
treatment
with
diverse
activation
pathways.
In
recent
years,
the
stimulator
of
interferon
genes
(STING)
signaling
pathway
has
exhibited
significant
potential
tumor
immunotherapy.
This
exerts
notable
antitumor
effects
by
activating
innate
and
adaptive
immunity
regulating
immune
microenvironment.
Various
metal
ions
have
been
identified
as
effective
activators
STING
and,
through
design
synthesis
nanodelivery
platforms,
applied
immunotherapy
well
combination
therapies,
such
chemotherapy,
chemodynamic
therapy,
photodynamic
vaccines.
Metal
nanomaterials
showcase
unique
advantages
immunotherapy;
however,
there
are
still
aspects
that
require
optimization.
review
systematically
examines
existing
metal-based
nanomaterials,
elaborates
on
mechanisms
which
different
activate
pathway,
discusses
their
application
models
therapies.
We
also
provide
comparative
analysis
over
other
methods.
Our
exploration
highlights
broad
prospects
treatment,
offering
new
insights
directions
for
advancement
Materials Today Bio,
Journal Year:
2024,
Volume and Issue:
29, P. 101328 - 101328
Published: Nov. 6, 2024
Acute
kidney
injury
(AKI)
induced
by
cisplatin
(DDP),
which
is
accompanied
with
the
generation
of
reactive
oxygen
species
(ROS),
a
severe
side
effect
during
treatment
and
restricts
application
DDP.
In
this
study,
we
develop
ultrasmall
Mn